NFKB1 and lung carcinoma: Those NF-κB inhibitors exert anti-tumor or antiviral effects in lung cancer or COVID-19 mainly affecting NF-κB induction, NF-κB nuclear translocation, and DNA binding (90), all of which have interrelation with ROS as indicated above.